An AI-powered blood test that reads DNA fragmentation patterns could detect early liver damage—and possibly other chronic diseases—years before symptoms emerge. Credit: Shutterstock Researchers at the Johns Hopkins Kimmel Cancer Center have developed an artificial intelligence (AI) driven liquid biopsy that analyzes genome wide patterns of cell free DNA (cfDNA) fragments circulating in the blood. The test examines how these DNA pieces break apart and where they appear across the genome. Using

Tag-uri: DNA